Morgan Stanley Maintains Equal-Weight on Axsome Therapeutics, Raises Price Target to $251

Benzinga · 2d ago
Morgan Stanley analyst Sean Laaman maintains Axsome Therapeutics (NASDAQ:AXSM) with a Equal-Weight and raises the price target from $242 to $251.